GTC
Ghost Tree Capital Portfolio holdings
AUM
$276M
This Quarter Return
+16.05%
1 Year Return
+49.13%
3 Year Return
+198.45%
5 Year Return
+1,783.74%
10 Year Return
+9,775.89%
AUM
$108M
AUM Growth
–
Cap. Flow
+$108M
Cap. Flow
% of AUM
100%
Top 10 Holdings %
Top 10 Hldgs %
41.79%
Holding
59
New
52
Increased
–
Reduced
–
Closed
–
Top Buys
| 1 |
Gilead Sciences
GILD
|
$10.1M |
| 2 |
Bristol-Myers Squibb
BMY
|
$5.32M |
| 3 |
Biogen
BIIB
|
$4.47M |
| 4 |
SPNC
Spectranetics Corp
SPNC
|
$4.38M |
| 5 |
Accuray
ARAY
|
$3.92M |
Top Sells
No sells this quarter
Sector Composition
| 1 | Healthcare | 75.1% |
| 2 | Technology | 1.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
WINT
51
DELISTED
Windtree Therapeutics Inc
WINT
| $225K | 0.14% |
+100,000
| New | +$225K |
|
|
AGN
52
DELISTED
ALLERGAN INC
AGN
| – | – |
0
| – | – |
|
|
AUXL
53
DELISTED
AUXILIUM PHARAMCEUTICALS INC
AUXL
| – | – |
0
| – | – |
|
|
THOR
54
DELISTED
THORATEC CORPORATION
THOR
| – | – |
0
| – | – |
|
55
Vertex Pharmaceuticals
VRTX
$102B
| – | – |
0
| – | – |
|
56
Teva Pharmaceuticals
TEVA
$21.5B
| – | – |
0
| – | – |
|
57
Edwards Lifesciences
EW
$47.7B
| – | – |
0
| – | – |
|
|
NUVA
58
DELISTED
NuVasive, Inc.
NUVA
| – | – |
0
| – | – |
|